Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29460203 | 1.00 | MAOB (0.71) | MAOBMAOA | |
| SCHEMBL11070224 | 0.99 | MAOB (0.72) | MAOBMAOA | |
| SCHEMBL30546591 | 0.96 | MAOB (0.70) | MAOBMAOA | |
| SCHEMBL252282 | 0.96 | MAOB (0.70) | MAOBMAOA | |
| SCHEMBL2842062 | 0.93 | MAOB (0.80) | MAOBMAOA | |
| SCHEMBL17848639 | 0.92 | MAOB (0.68) | MAOBMAOA | |
| SCHEMBL29923843 | 0.92 | MAOB (0.68) | MAOBMAOA | |
| SCHEMBL1036438 | 0.89 | MAOB (0.67) | MAOBMAOA | |
| SCHEMBL14188953 | 0.88 | MAOB (0.57) | MAOBMAOA | |
| SCHEMBL11276922 | 0.88 | MAOB (0.65) | MAOBMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 361 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115340494-A | Synthesis method of high-purity aripiprazole | 安徽修一制药有限公司 | 2022-11-15 | — | — | CN | claimed |
| CN-113214150-A | Synthesis of high-purity aripiprazole and preparation method of hydrate particles thereof | 北京逸诚医药科技有限公司 | 2021-08-06 | — | — | CN | claimed |
| EP-2408748-A2 | ARIPIPRAZOLE SALTS | Kozluk, Tomasz (PL) | 2012-01-25 | — | — | EP | claimed |
| WO-2011030213-A8 | IMPROVED PROCESS FOR THE PREPARATION OF 7-(4-BROMOBUTOXY) 3,4-DIHYDROCARBOSTYRIL, A PRECURSOR OF ARIPIPRAZOLE | JUBILANT LIFE SCIENCES LIMITED (IN) | 2011-05-19 | — | — | WO | claimed |
| WO-2011030213-A1 | IMPROVED PROCESS FOR THE PREPARATION OF 7.(4-BROMOBUTOXY) 3,4-DIHYDROCARBOSTYRIL, A PRECURSOR OF ARIPIPRAZOLE | JUBILANT ORGANOSYS LIMITED (IN) | 2011-03-17 | — | — | WO | claimed |
| WO-2010107329-A2 | ARIPIPRAZOLE SALTS | KOZLUK TOMASZ (PL) | 2010-09-23 | — | — | WO | claimed |
| US-20100130744-A1 | PROCESS FOR THE PREPARATION OF ARIPIPRAZOLE | AUROBINDO PHARMA LTD (IN) | 2010-05-27 | — | — | US | claimed |
| US-20090198059-A1 | Process for the preparation of polymorphs, solvates of aripiprazole using aripirazole acid salts | SATYANARAYANA CHAVA | 2009-08-06 | — | — | US | claimed |
| WO-2008146156-A2 | AN IMPROVED PROCESS FOR THE PREPARATION OF ARIPIPRAZOLE | AUROBINDO PHARMA LIMITED (IN) | 2008-12-04 | — | — | WO | claimed |
| US-7361756-B2 | Method of making 7-(4-bromobutoxy)-3,4-dihydrocarbostyril | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2008-04-22 | — | — | US | claimed |
| JP-2007517916-A | — | — | 2007-07-05 | — | — | JP | claimed |
| EP-1797039-A1 | PROCESS FOR THE PREPARATION OF POLYMORPHS, SOLVATES OF ARIPIPRAZOLE USING ARIPIPRAZOLE ACID SALTS | Matrix Laboratories Ltd (IN) | 2007-06-20 | — | — | EP | claimed |
| EP-1765782-A1 | METHOD OF MAKING 7-(4-BROMOBUTOXY)-3,4-DIHYDROCARBOSTYRIL | Teva Pharmaceutical Industries Ltd (IL) | 2007-03-28 | — | — | EP | claimed |
| US-20060258869-A1 | Process for the preparation of aripiprazole | ALEMBIC LIMITED (IN) | 2006-11-16 | — | — | US | claimed |
| EP-1711466-A1 | PROCESS FOR PREPARING ARIPIPRAZOLE | Teva Pharmaceutical Industries Ltd (IL) | 2006-10-18 | — | — | EP | claimed |
| WO-2006030446-A1 | PROCESS FOR THE PREPARATION OF POLYMORPHS, SOLVATES OF ARIPIPRAZOLE USING ARIPIPRAZOLE ACID SALTS | MATRIX LABORATORIES LTD (IN) | 2006-03-23 | — | — | WO | claimed |
| WO-2006001846-A1 | METHOD OF MAKING 7-(4-BROMOBUTOXY)-3,4-DIHYDROCARBOSTYRIL | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2006-01-05 | — | — | WO | claimed |
| US-20050215585-A1 | Method of making 7-(4-bromobutoxy)-3,4-dihydrocarbostyril | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2005-09-29 | — | — | US | claimed |
| US-20050215791-A1 | Process for preparing aripiprazole | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2005-09-29 | — | — | US | claimed |
| WO-2005077904-A1 | PROCESS FOR PREPARING ARIPIPRAZOLE | TEVA PHARMACEUTICAL INDUSTRIES, LTD. (IL) | 2005-08-25 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100130744-A1 | PROCESS FOR THE PREPARATION OF ARIPIPRAZOLE | CYP3A4, CYP2C19, CYP2F1 | MAOB 70/4885MAOA 78/4885 |
| US-20060258869-A1 | Process for the preparation of aripiprazole | CYP2F1, CYP3A4, CYP2A7 | MAOB 133/4885MAOA 260/4885 |
| US-20090198059-A1 | Process for the preparation of polymorphs, solvates of aripiprazole using aripirazole acid salts | CYP3A4, CYP3A5, CYP3A43 | MAOB 324/4885MAOA 142/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.